Employment AgreementEmployment Agreement • March 16th, 2022 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (this “Agreement”), dated as of October 29, 2020, is made by and between SQZ Biotechnologies Company, a Delaware corporation (together with any successor thereto, the “Company”), and David First (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
November 3, 2021 Via Email - Personal and Confidential Dear Teri,SQZ Biotechnologies Co • March 16th, 2022 • Biological products, (no disgnostic substances) • Massachusetts
This letter (the “Agreement”) summarizes the terms of your separation from employment with SQZ Biotechnologies Company (“SQZ” or the “Company”) and establishes an amicable arrangement under which you release the Company from any claims, and, in return, you receive severance pay.
TRANSITION CONSULTING AGREEMENTTransition Consulting Agreement • March 16th, 2022 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances) • Massachusetts
This Consulting Agreement (this "Agreement") dated as of November 11, 2021, the “Effective Date”), is made by and between SQZ Biotechnologies Company, a Delaware corporation (the "Company"), and Teri Loxam (the "Consultant").
